---
category: news
title: "Arbor Day: Gene-Edited Therapy Developer Completes $215M Series B"
excerpt: "Arbor Biotechnologies, a developer of gene-edited precision therapies co-founded by CRISPR pioneer Feng Zhang, PhD, has more than doubled its total capitalization after completing a $215 million Series B financing."
publishedDateTime: 2021-11-09T20:32:00Z
originalUrl: "https://www.genengnews.com/topics/genome-editing/arbor-day-gene-edited-therapy-developer-completes-215m-series-b/"
webUrl: "https://www.genengnews.com/topics/genome-editing/arbor-day-gene-edited-therapy-developer-completes-215m-series-b/"
type: article
quality: 39
heat: 39
published: false

provider:
  name: GEN
  domain: genengnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.genengnews.com/wp-content/uploads/2021/11/NIH-crispr-1.jpg"
    width: 873
    height: 582
    isCached: true

secured: "8UpcBk2KY6jmRRHmiig36k+ODH4XvVpxKTnF7OWqW7k2yE6XcNnuBEpyOe88EtbHIzzbob9pYWhNrSr4NVZNg6692Fx1emZr/SCPeLJvyksW4Bl56xUfpL2MhwIn7IOljcSHgBFaensZrd1S4K0gvowcpWJKyoVfBzYmqXftCOReEN5gAup5UdHBEBxT2SsDL4cwOKxcMrIA6sjcaVrFEii0SWnqoxbkbTXcFoBWtPvV54E/bPdCS2LNFetKeNB9Y+lKxrOuMKtDdOJyg2K0418DBSNBi4wfUFaoHpU1Y9zHWpBUDb+EHeoZMl9qGQV7YZiX1cbd5tPvDCvGO2hi0496UEdwchvD2QzjpDUSCgQ=;KLmttROhzgwmynhN3eNjOw=="
---

